Clinical significance of acid-base balance in an emergency setting in patients with acute heart failure

Journal of Cardiology

Volumn 60, Issue 4, 2012, Pages 288-294

  Shirakabe, Akihiro ^a   Hata, Noritake ^a   Kobayashi, Nobuaki ^a   Shinada, Takuro ^a   Tomita, Kazunori ^a   Tsurumi, Masafumi ^a   Matsushita, Masato ^a   Okazaki, Hirotake ^a   Yamamoto, Yoshiya ^a   Yokoyama, Shinya ^a   Asai, Kuniya ^a   Mizuno, Kyoichi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Acute heart failure syndrome; Arterial blood gas analysis; Mortality

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN;

ACID BASE BALANCE; ACIDOSIS; ACUTE HEART FAILURE; ADULT; AGED; ALKALOSIS; ARTERIAL GAS; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; EMERGENCY PATIENT; FEMALE; HEART RATE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; KAPLAN MEIER METHOD; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROTEIN BLOOD LEVEL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ACID-BASE EQUILIBRIUM; ACUTE DISEASE; AGED; ARTERIES; BLOOD GAS ANALYSIS; EMERGENCIES; FEMALE; HEART FAILURE; HUMANS; INTENSIVE CARE UNITS; MALE; PROGNOSIS;

EID: 84866537610     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2012.06.004     Document Type: Article

References (33)

1. Dickstein K., Cohen-Solal A., Filippatos G., McMurray J.J., Ponikowski P., Poole-Wilson P.A., Strömberg A., van Veldhuisen D.J., Atar D., Hoes A.W., Keren A., Mebazaa A., Nieminen M., Priori S.G., Swedberg K., et al. Eur Heart J 2008, 29:2388-2442.
2. Jessup M., Abraham W.T., Casey D.E., Feldman A.M., Francis G.S., Ganiats T.G., Konstam M.A., Mancini D.M., Rahko P.S., Silver M.A., Stevenson L.W., Yancy C.W. Circulation 2009, 119:1977-2016. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.
3. Adams K.F., Fonarow G.C., Emerman C.L., LeJemtel T.H., Costanzo M.R., Abraham W.T., Berkowitz R.L., Galvao M., Horton D.P. Am Heart J 2005, 149:209-216. ADHERE Scientific Advisory Committee and Investigators. ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).
4. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., Fukuchi Y., Jenkins C., Rodriguez-Roisin R., van Weel C., Zielinski J. Am J Respir Crit Care Med 2007, 176:532-555. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
5. Camargo C.A., Rachelefsky G., Schatz M. Managing asthma exacerbations in the emergency department: summary of the National Asthma Education and Prevention Program Expert Panel Report 3 guidelines for the management of asthma exacerbations. J Emerg Med 2009, 37(Suppl. 2):S6-S17.
6. Miñana G., Núñez J., Bañuls P., Sanchis J., Núñez E., Robles R., Mascarell B., Palau P., Chorro F.J., Llàcer A. Prognostic implications of arterial blood gases in acute decompensated heart failure. Eur J Intern Med 2011, 22:489-494.
7. Gheorghiade M., Zannad F., Sopko G., Klein L., Piña I.L., Konstam M.A., Massie B.M., Roland E., Targum S., Collins S.P., Filippatos G., Tavazzi L. Acute heart failure syndromes: current state and framework for future research. Circulation 2005, 112:3958-3968. International Working Group on Acute Heart Failure Syndromes.
8. Nieminen M.S., Harjola V.P. Definition and epidemiology of acute heart failure syndromes. Am J Cardiol 2005, 96:5G-10G.
9. Mebazaa A., Gheorghiade M., Piña I.L., Harjola V.P., Hollenberg S.M., Follath F., Rhodes A., Plaisance P., Roland E., Nieminen M., Komajda M., Parkhomenko A., Masip J., Zannad F., Filippatos G. Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes. Crit Care Med 2008, 36(Suppl. 1):S129-S139.
10. Pappas L., Filippatos G. Pulmonary congestion in acute heart failure: from hemodynamics to lung injury and barrier dysfunction. Rev Esp Cardiol 2011, 64:735-738.
11. Natanzon A., Kronzon I. Pericardial and pleural effusions in congestive heart failure-anatomical, pathophysiologic, and clinical considerations. Am J Med Sci 2009, 338:211-216.
12. Frangiosa A., De Santo L.S., Anastasio P., De Santo N.G. Acid-base balance in heart failure. J Nephrol 2006, 19(Suppl. 9):S115-S120.
13. Hsu C.W., Chen H.H., Sheu W.H., Chu S.J., Shen Y.S., Wu C.P., Chien K.L. Initial serum glucose level as a prognostic factor in the first acute myocardial infarction. Ann Emerg Med 2007, 49:618-626.
14. Pattan V., Parsaik A., Brown J.K., Kudva Y.C., Vlahakis N., Basu A. Glucose control in mayo clinic intensive care units. J Diabetes Sci Technol 2011, 5:1420-1426.
15. Kosuge M., Kimura K., Morita S., Kojima S., Sakamoto T., Ishihara M., Asada Y., Tei C., Miyazaki S., Sonoda M., Tsuchihashi K., Yamagishi M., Shirai M., Hiraoka H., Honda T., et al. Combined prognostic utility of white blood cell count, plasma glucose, and glomerular filtration rate in patients undergoing primary stent placement for acute myocardial infarction. Am J Cardiol 2009, 103:322-327.
16. Chen J.H., Tseng C.L., Tsai S.H., Chiu W.T. Initial serum glucose level and white blood cell predict ventricular arrhythmia after first acute myocardial infarction. Am J Emerg Med 2010, 28:418-423.
17. Oswald G.A., Smith C.C., Betteridge D.J., Yudkin J.S. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed) 1986, 293:917-922.
18. Wen D., Wu H.Y., Jiang X.J., Zhang H.M., Zhou X.L., Li J.J., Hui R.T. Role of plasma C-reactive protein and white blood cell count in predicting in-hospital clinical events of acute type A aortic dissection. Chin Med J (Engl) 2011, 124:2678-2682.
19. Pfister R., Sharp S.J., Luben R., Wareham N.J., Khaw K.T. Differential white blood cell count and incident heart failure in men and women in the EPIC-Norfolk study. Eur Heart J 2011, 33:523-530.
20. Engstrom G., Melander O., Hedblad B. Leukocyte count and incidence of hospitalizations due to heart failure. Circ Heart Fail 2009, 2:217-222.
21. Michowitz Y., Arbel Y., Wexler D., Sheps D., Rogowski O., Shapira I., Berliner S., Keren G., George J., Roth A. Predictive value of high sensitivity CRP in patients with diastolic heart failure. Int J Cardiol 2008, 125:347-351.
22. Suleiman M., Khatib R., Agmon Y., Mahamid R., Boulos M., Kapeliovich M., Levy Y., Beyar R., Markiewicz W., Hammerman H., Aronson D. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein. J Am Coll Cardiol 2006, 47:962-968.
23. Gheorghiade M., Abraham W.T., Albert N.M., Greenberg B.H., O'Connor C.M., She L., Stough W.G., Yancy C.W., Young J.B., Fonarow G.C. JAMA 2006, 296:2217-2226. OPTIMIZE-HF Investigators and Coordinators. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure.
24. Kociol R.D., Greiner M.A., Hammill B.G., Phatak H., Fonarow G.C., Curtis L.H., Hernandez A.F. Long-term outcomes of Medicare beneficiaries with worsening renal function during hospitalization for heart failure. Am J Cardiol 2010, 12:1786-1793.
25. Núñez J., Núñez E., Fonarow G.C., Sanchis J., Bodí V., Bertomeu-González V., Miñana G., Merlos P., Bertomeu-Martínez V., Redón J., Chorro F.J., Llàcer A. Differential prognostic effect of systolic blood pressure on mortality according to left-ventricular function in patients with acute heart failure. Eur J Heart Fail 2010, 12:38-44.
26. Planquette B., Le Pimpec-Barthes F., Trinquart L., Meyer G., Riquet M., Sanchez O. Early respiratory acidosis is a new risk factor for pneumonia after lung resection. Interact Cardiovasc Thorac Surg 2012, 14:244-248.
27. Bhadade R.R., de Souza R.A., Harde M.J., Khot A. Clinical characteristics and outcomes of patients with acute lung injury and ARDS. J Postgrad Med 2011, 57:286-290.
28. Kasotakis G., Schmidt U., Perry D., Grosse-Sundrup M., Benjamin J., Ryan C., Tully S., Hirschberg R., Waak K., Velmahos G., Bittner E.A., Zafonte R., Cobb J.P., Eikermann M. The surgical intensive care unit optimal mobility score predicts mortality and length of stay. Crit Care Med 2012, 40:1122-1128.
29. Shirakabe A., Hata N., Yokoyama S., Shinada T., Kobayashi N., Tomita K., Kitamura M., Nozaki A., Tokuyama H., Asai K., Mizuno K. Predicting the success of noninvasive positive pressure ventilation in emergency room for patients with acute heart failure. J Cardiol 2011, 57:107-114.
30. Harjola V.P., Follath F., Nieminen M.S., Brutsaert D., Dickstein K., Drexler H., Hochadel M., Komajda M., Lopez-Sendon J.L., Ponikowski P., Tavazzi L. Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure. Eur J Heart Fail 2010, 12:239-248.
31. Hata N., Seino Y., Tsutamoto T., Hiramitsu S., Kaneko N., Yoshikawa T., Yokoyama H., Tanaka K., Mizuno K., Nejima J., Kinoshita M. Circ J 2008, 11:1787-1793. Effects of carperitide on the long-term prognosis of patients with acute decompensated chronic heart failure: the PROTECT multicenter randomized controlled study.
32. Shirakabe A., Asai K., Hata N., Yokoyama S., Shinada T., Kobayashi N., Tomita K., Tsurumi M., Matsushita M., Mizuno K. Immediate administration of atorvastatin decreased the serum MMP-2 level and improved the prognosis for acute heart failure. J Cardiol 2012, 59:374-382.
33. Siirilä-Waris K., Lassus J., Melin J., Peuhkurinen K., Nieminen M.S., Harjola V.P. Eur Heart J 2006, 27:3011-3017. FINN-AKVA Study Group. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure.